Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017

... to evaluate the functioning of coronary arteries. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinsons disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, ...

http://www.sys-con.com/node/2598690